Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research Grade HuJ591-Gsmab | Login | Research Grade HuJ591-Gsmab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Rosopatamab | Login | Research Grade Rosopatamab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Glembatumumab | Login | Research Grade Glembatumumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Icrucumab | Login | Research Grade Icrucumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Ifabotuzumab | Login | Research Grade Ifabotuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Imalumab | Login | Research Grade Imalumab | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD371/CLEC12A Antibody (SAA0102) | Login | Anti-Human CD371/CLEC12A Antibody (SAA0102) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human SIGLEC15/CD33L3 Antibody (25E9#) | Login | Anti-Human SIGLEC15/CD33L3 Antibody (25E9#) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human SIGLEC15/CD33L3 Antibody (A9E8) | Login | Anti-Human SIGLEC15/CD33L3 Antibody (A9E8) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD25/IL2RA Antibody (PC61/PC61.5.3) | Login | Anti-Mouse CD25/IL2RA Antibody (PC61/PC61.5.3) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD3E Antibody (145-2C11) | Login | Anti-Mouse CD3E Antibody (145-2C11) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD3E Antibody (145-2C11) | Login | Anti-Mouse CD3E Antibody (145-2C11) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD3E Antibody (500A2) | Login | Anti-Mouse CD3E Antibody (500A2) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD4 Antibody (GK1.5) | Login | Anti-Mouse CD4 Antibody (GK1.5) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD47/MER6 Antibody (A4) | Login | Anti-Mouse CD47/MER6 Antibody (A4) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD70 Antibody (FR70) | Login | Anti-Mouse CD70 Antibody (FR70) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD71/TFRC Antibody (R17217) | Login | Anti-Mouse CD71/TFRC Antibody (R17217) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD8a/Lyt2 Antibody (2.43) | Login | Anti-Mouse CD8a/Lyt2 Antibody (2.43) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD279/PDCD1/PD1 Antibody (J43V2) | Login | Anti-Mouse CD279/PDCD1/PD1 Antibody (J43V2) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD3E Antibody (145-2C11) | Login | Anti-Mouse CD3E Antibody (145-2C11) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD8a/Lyt2 Antibody (YTS105.18) | Login | Anti-Mouse CD8a/Lyt2 Antibody (YTS105.18) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD8a/Lyt2 Antibody (X118) | Login | Anti-Mouse CD8a/Lyt2 Antibody (X118) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD8a/Lyt2 Antibody (19.178#) | Login | Anti-Mouse CD8a/Lyt2 Antibody (19.178#) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD8a/Lyt2 Antibody (53-6.72) | Login | Anti-Mouse CD8a/Lyt2 Antibody (53-6.72) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD8 Antibody (MSE10) | Login | Anti-Mouse CD8 Antibody (MSE10) | ||||||||||||||||
|
||||||||||||||||||


